AbbVie CFO discusses strategies; Biz started by former Pfizer folks expanding; Bayer gets Teva animal biz;

@FiercePharma: Here's evidence of Vivus growth expectations: New HQ space almost 3X the size of current offices. More | Follow @FiercePharma

 @EricPFierce: The FDA approved nearly a dozen new cancer drugs in 2012, but also drugs for erectile dysfunction weight-loss. Special Report | Follow @EricPFierce

 @AlisonBFierce: Eli Lilly will step up to the plate to defend against DES litigation. News | Follow @AlisonBFierce

> AbbVie ($ABBV) CFO William Chase says Big Pharma's newest company intends to provide investors with a dividend in the short term while it works on a pipeline of novel drugs for the longer term. Story

> Bayer HealthCare is now the proud owner of the animal health business that it bought from Teva Pharmaceutical Industries ($TEVA) for $60 million up front and up to $85 million in additional payments. Story

> The FDA has turned back another attempt by K-V Pharmaceuticals ($KV.A) to keep competition to its Makena drug for premature births off the market. Story

> Ameridose, which has common ownership with the compounding pharmacy at the heart of the meningitis outbreak that has killed 39, will remain closed another 6 weeks while regulators continue their investigation into "unsanitary conditions." Story

> Watson Pharmaceuticals ($WPI) says the FDA has approved its generic version of Ferring Pharmaceuticals' Lysteda, used for treating heavy menstrual bleeding. Item

> LGC, a company set up by two former Pfizer ($PFE) employees at the former Pfizer site in Kent England, expects to expand this year. Item

Medical Device News

 @FierceMedDev: Halt Medical snags $15M to launch uterine fibroid device. Story | Follow @FierceMedDev

@MarkHFierce: We at Fierce are gearing up for some major coverage of JPM13. The fun starts Monday in San Francisco. Editor's Corner | Follow @MarkHFierce

 @DamianFierce: Hologic is selling off one of the business units it acquired in last year's $3.8B Gen-Probe buy. News | Follow @DamianFierce

> GI Dynamics teams up with Medtronic, GSK for EndoBarrier research. News

> The U.K.'s Wellcome Trust unveils VC fund for devices, Dx and others. Article

> Atossa revs up national sales rollout for handheld breast cancer Dx. Story

Biotech News

 @FierceBiotech: Slideshow: FDA Approvals of 2012. More | Follow @FierceBiotech

@RyanMFierce: $BIIB has filed for FDA approval of long-lasting clotting factor in hemophilia B, a new area for the biotech giant. More | Follow @RyanMFierce

> UCSD biotech spinoff snags $18M A round to advance RNAi drugs. Article

> Amicus jumps on upbeat data for Pompe drug. News

And Finally... A study finds that patients are less likely to take their meds when they are changed to generics whose color or shape is different than the branded products they replaced. Story